Register entry

Agios Pharmaceuticals, Inc.

Registered sites
0
Drug products
7
Live patents
33
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Exclusivity

Patents

33

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
AQVESMEMITAPIVAT SULFATEMay 2032
AQVESMEMITAPIVAT SULFATEOct 2032
AQVESMEMITAPIVAT SULFATEApr 2035
AQVESMEMITAPIVAT SULFATENov 2038
AQVESMEMITAPIVAT SULFATEJul 2041
PYRUKYNDMITAPIVAT SULFATEMay 2032
PYRUKYNDMITAPIVAT SULFATEOct 2032
PYRUKYNDMITAPIVAT SULFATEApr 2033
PYRUKYNDMITAPIVAT SULFATEApr 2035
PYRUKYNDMITAPIVAT SULFATEOct 2038
PYRUKYNDMITAPIVAT SULFATENov 2038
PYRUKYNDMITAPIVAT SULFATEJul 2041
Catalogue

Marketed products

7

Showing 7 of 7.

BrandGeneric nameFormCategory
AQVESMEmitapivatTABLET, FILM COATEDNDA
PYRUKYNDmitapivatTABLET, FILM COATEDNDA
PYRUKYNDmitapivatTABLET, FILM COATEDNDA
PYRUKYNDmitapivatTABLET, FILM COATEDNDA
PYRUKYNDmitapivatTABLET, FILM COATEDNDA
PYRUKYNDmitapivatKITNDA
PYRUKYNDmitapivatKITNDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.